LID.L Regulatory News (LID)

LiDCO Group Plc

("LiDCO" or the "Company")

Showcasing Portable LiDCO Stand System at the ISICEM Brussels

LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, will be attending the International Symposium on Intensive Care and Emergency Medicine ('ISICEM'), one of the largest trade shows in its field, attracting globally more than 6,200 participants and will be showcasing its new portable LiDCO Battery Monitor Stand System ('BMSS') for the first time.

LiDCO will be showcasing the Company's products along with its new portable LiDCO BMSS at stand 1.07 -1.08 throughout the trade show which is being held today (Tuesday 17 March 2015) through till Friday 20 March 2015.

The portability of LiDCO's BMSS when combined with the existing non-invasive functionality creates many benefits for users of LiDCO's technology. The LiDCOrapid monitor can now be used mains free on battery power for up to six hours allowing it to be moved to different locations in the hospital where mains power might not be easily available. It can be used in pre-anaesthesia rooms to monitor fluid and drug requirements after anaesthetic induction and then keep continuously monitoring the patient as they are moved to the operating room. It can accompany the patient from the operating room to the post-operative recovery or intensive care ward, allowing practitioners a continuous hemodynamic monitoring record of both the surgery and recovery periods on a single monitor. It also allows it to be used within A&E as it can be more easily moved to assess and screen shock patients potentially requiring fluid resuscitation.

The LiDCO BMSS received the certification required by the medical standard IEC 60601-1 (a series of technical standards for the safety and effectiveness of medical electrical equipment) on Friday 13 March 2015. The development of the BMSS will allow LiDCO access to even more patients that need real-time hemodynamic monitoring, helping to reduce morbidity and complications, length of stay in hospital and overall costs associated with major surgery.

ISICEM is geared towards giving participants an understanding of the most recent, clinical relevant, developments in research and the management of the critically ill which makes it an ideal show to launch the LiDCO BMSS.

Commenting, Terry O'Brien, Chief Executive Officer of LiDCO, said: "We are delighted to be exhibiting at one of the industry's largest trade shows this week. The event brings together professionals with an interest in critical care, surgery and emergency medicine making it the perfect place to showcase our new portable LiDCO Battery Monitor Stand System. We strive to add features to our technology that allow our advanced hemodynamic monitoring to be available for the entire patient pathway, from the emergency room to the recovery ward. The non-invasive nature of our LiDCOrapid v2 monitor coupled to this enhanced portability more fully addresses anesthetic work flow and fluid and drug management now spanning the acute phase of high-risk patients wherever they might be in the hospital."

The event is being held at Brussels Meeting Centre, Glass Entrance, rue Mont des Arts, 1000 Brussels, Belgium. For further information, please go to: www.intensive.org

For further information, please contact:

About LiDCO Group Plc (www.lidco.com)

LiDCO is a supplier of non-invasive and minimally invasive hemodynamic equipment to hospitals used to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimisation protocols for high risk patients in both critical care units and in the operating theatre. 

Increasingly clinical studies are showing that the optimisation of patients' hemodynamic status in high risk patients produces better outcomes and reduced hospital stay. LiDCO's computer-based technology, developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery.

Key Products:

LiDCOplus: a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%).

LiDCOrapid: a cardiac output monitor designed specifically for use in the operating theatre for fluid and drug management. The monitor enables anaesthetists to receive accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being before, during and after surgery. The LiDCOrapid provides:

· early and rapid warning of hemodynamic change to aid choice of therapeutic route: fluid or drug

· quantification of hemodynamic response

· guidance on effective delivery of fluids to ensure the right amount at the right time

LiDCOview: an easy-to-use graphical display of historical LiDCOplus and LiDCOrapid hemodynamic data.

LiDCO Unity Software: software incorporated into LiDCOrapid v2 that allows the LiDCOrapid monitor to co-display Covidien's level of consciousness parameter ('BISTM')* and add the convenience of CNSystem's continuous non-invasive blood pressure monitoring ('CNAP')**. This will address a growing requirement for non-invasive monitoring solutions that are more comprehensive and can effectively replace multiple single parameter monitors. 

*BISTM and Bispectral Index are trademarks of Covidien LP registered in the US and foreign countries.

* CNAPTM is a trademark of CNSystems Medizintechnik AG.

LiDCO monitors use single-patient disposables (sensors or smartcards) which provide an ongoing revenue stream.

LiDCO Distribution Network:

LiDCO sells directly to hospitals in the UK and USA and through a network of specialty critical care and anaesthesia distributors in the rest of the world.

LiDCO's marketing office is in Cambridge, its manufacturing facility and headquarters are in London and its shares are traded on AIM.